Dynamic EMT: a multi‐tool for tumor progression

By Simone Brabletz, Harald Schuhwerk, Thomas Brabletz, Marc P. Stemmler. EMBO Journal, 2021

600 citations recorded by the source corpus.

The process of epithelial–mesenchymal transition (EMT) is fundamental for embryonic morphogenesis. Cells undergoing it lose epithelial characteristics and integrity, acquire mesenchymal features, and become motile. In cancer, this program is hijacked to confer essential changes in morphology and motility that fuel invasion. In addition, EMT is increasingly understood to orchestrate a large variety of complementary cancer features, such as tumor cell stemness, tumorigenicity, resistance to therapy and adaptation to changes in the microenvironment. In this review, we summarize recent findings related to these various classical and non‐classical functions, and introduce EMT as a true tumorigenic multi‐tool, involved in many aspects of cancer. We suggest that therapeutic targeting of the EMT process will—if acknowledging these complexities—be a possibility to concurrently interfere with tumor progression on many levels.

Subfields: Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/1818f15ad48b9e0b781b28d4fd23b20b502d386c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Yuhe Huang
2. Xiawei Wei
3. Weiqi Hong

In Oncology

1. Yuhe Huang
2. Xiawei Wei
3. Weiqi Hong

Citations in the corpus

• The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis (2022, background): “Increased drug efflux or avoidance of apoptosis and necrosis are the common pathways of drug resistance [19].”